Eclazolast

This classification denotes a histamine-1 receptor antagonist with the molecular formula C12H12ClNO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R5ELL4R7VD, chemically known as 2-benzoxazolecarboxylic acid, 5-chloro-, 2-ethoxyethyl ester but generally known as eclazolast, which bears US NIH Compound Identifier 54550. European Medicines Agency schedules Eclazolast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06448MIG. The term ECLAZOLAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). ECLAZOLAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule eclazolast under HS 29349990 and SITC 51579. As of Q4 2014, ECLAZOLAST remains the US FDA Preferred Term for this commodity. Eclazolast bears US NLM identifiers UMLS ID C0073137 and NCI Concept Code C81140. SMILES: CCOCCOC(=O)C1=NC2=C(O1)C=CC(=C2)CL.